(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

OLIGONUCLEOTÍDIOS ANTISENSO

ArquivadaInvention PatentPCT · GB2000004741

Application data

Number

PI0016347

Type

Invention Patent

Filing

12/12/2000

Publication

09/10/2002

PCT

GB2000004741

Progress at the INPI

  1. Filing12/12/00
  2. Publication09/10/02
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 12/12/2000 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 02/01/2005. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

Astrazeneca AB

SE

See this company's full portfolio

Inventors

B. R. (pessoa física)

GB

Technical data

IPC Classification

Priority claims

GB

9929487.8 · 12/15/1999

Abstract

"OLIGONUCLEOTÍDIOS ANTISENSO". A presente invenção proporciona oligonucleotídios antisenso que são efetivos na inibição da expressão de um gene COL1A1 do tipo selvagem.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

02/01/2005

RPI 1778

Arquivamento - Art. 33 da LPI

#11.1

07/13/2004

RPI 1749

Notificação de entrada na fase nacional - PCT

#1.3

09/10/2002

RPI 1653

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.